EC Number   |
Disease |
PubMed ID |
Title of Publication  |
Category |
Confidence Level |
|---|
   7.2.2.13 | Heart Failure |
18052902 |
"Don't flog the heart!" - development of specific drug therapies for heart failure. |
causal interaction
unassigned |
3
0 |
| 7.2.2.13 | Neoplasms |
22438768 |
"The Lower Threshold" phenomenon in tumor cells toward endogenous digitalis-like compounds: Responsible for tumorigenesis? |
ongoing research
unassigned |
4
0 |
| 7.2.2.13 | Myotonia |
123512 |
(Na+ + K+)-ATPase activity in rats with 20, 25-diazacholesterol-induced myotonia. |
ongoing research
unassigned |
1
0 |
| 7.2.2.13 | Retinal Diseases |
2551574 |
(Na+ + K+)-ATPase and opsin in retinas of RCS dystrophic rats: time course study. |
ongoing research
unassigned |
2
0 |
| 7.2.2.13 | Glioma |
3034973 |
(Na+ + K+)-ATPase in C6 glioma and rat cerebrum. |
diagnostic usage
ongoing research
therapeutic application
unassigned |
3
3
1
0 |
| 7.2.2.13 | Neoplasms |
25290152 |
21-Benzylidene digoxin: a proapoptotic cardenolide of cancer cells that up-regulates Na,K-ATPase and epithelial tight junctions. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
1
1
3
1 |
| 7.2.2.13 | Neoplasms |
26122772 |
?-Benzylidene digoxin derivatives synthesis and molecular modeling: Evaluation of anticancer and the Na,K-ATPase activity effect. |
ongoing research
unassigned |
4
0 |
| 7.2.2.13 | Hyperglycemia |
26063704 |
?3-Adrenoceptor activation relieves oxidative inhibition of the cardiac Na+-K+ pump in hyperglycemia induced by insulin receptor blockade. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
3
1
1
2 |
| 7.2.2.13 | Diabetic Cardiomyopathies |
26179604 |
?3-Adrenoceptor, glutathionylation, and diabetic cardiomyopathy. Focus on "?3-Adrenoceptor activation relieves oxidative inhibition of the cardiac Na+-K+ pump in hyperglycemia induced by insulin receptor blockade". |
causal interaction
therapeutic application
unassigned |
1
1
0 |
| 7.2.2.13 | Hyperglycemia |
26179604 |
?3-Adrenoceptor, glutathionylation, and diabetic cardiomyopathy. Focus on "?3-Adrenoceptor activation relieves oxidative inhibition of the cardiac Na+-K+ pump in hyperglycemia induced by insulin receptor blockade". |
causal interaction
therapeutic application
unassigned |
1
1
0 |
